Loading organizations...
§ Private Profile · Los Angeles, CA, USA
Healthcare technology company developing AI software and operating medical networks for patient outcomes, public health, and providers.
Akido Labs has raised $60.0M across 1 funding round.
Key people at Akido Labs.
Akido Labs was founded in 2015 by Jared Goodner (Founder) and Prashant Samant (Founder).
Akido Labs has raised $60.0M in total across 1 funding round.
Based in Los Angeles, California, Akido Labs is a healthcare technology company that develops artificial intelligence software and operates medical networks to modernize clinical care delivery. The organization provides standardized API layers for hospital systems and utilizes its proprietary ScopeAI platform to manage medical visits from initial intake through diagnosis. In addition to licensing its software platform to government agencies and health systems, the enterprise directly delivers care by partnering with and acquiring physician practices. Backed by early investor Y Combinator, the company employs approximately 1,000 people and recently secured a $60 million Series B funding round to expand its operations. Its technology and clinical network serve various healthcare providers, including Chaparral Medical Group and Rhode Island Primary Care Physicians Corp. Akido Labs was founded in 2015 by Jared Goodner and Prashant Samant.
Key people at Akido Labs.
Akido Labs is a healthcare technology company founded in 2015 that aims to rebuild healthcare with AI at its core, making exceptional, personalized healthcare universally accessible regardless of socioeconomic status or geography. Their mission is to leverage advanced artificial intelligence and the latest medical advancements to create a healthcare system that anticipates patient needs, delivers precision care, and dramatically improves access and outcomes for all populations, including vulnerable groups such as the homeless and those with chronic diseases[1][2][4].
Akido Labs builds Scope AI, a proprietary AI operating system trained on extensive health data and clinician input, designed to transform the care experience by enabling hyper-personalized care and population health management at scale. Their platform serves healthcare providers, government agencies, and public health organizations, helping them predict patient needs and intervene proactively. The company has demonstrated strong growth with over 620,000 patient visits annually, 245 doctors, and 96 locations, reflecting significant momentum in expanding AI-driven healthcare delivery[1][3][4].
Akido Labs was founded in 2015 by Jared Goodner and Prashant Samant in Los Angeles, California. The founders brought a vision of combining cutting-edge AI technology with compassionate healthcare to address systemic inequities in access and quality. The idea emerged from recognizing that today’s best medical technologies were largely inaccessible to most people and that AI could be the key to democratizing healthcare[1][4].
Early traction came from developing AI tools that integrate diverse health and social data to predict and manage complex health challenges, especially for underserved populations. This focus on holistic, data-driven care and the ability to scale AI-powered solutions helped Akido Labs evolve rapidly into a leader in healthcare AI innovation[2][4].
Akido Labs rides the wave of AI-driven transformation in healthcare, a sector historically burdened by inefficiencies, inequities, and fragmented data. The timing is critical as breakthroughs in AI, data integration, and telehealth converge with growing demand for personalized, accessible care. Market forces such as rising chronic disease prevalence, healthcare cost pressures, and social determinants of health awareness favor Akido’s approach[1][2].
By pioneering an AI operating system for healthcare, Akido Labs influences the broader ecosystem by setting new standards for predictive, proactive care that integrates clinical and social data. Their work supports the shift toward value-based care models and population health management, helping healthcare providers and public agencies improve outcomes and reduce costs[2][4].
Looking ahead, Akido Labs is poised to expand Scope AI’s reach across the U.S., scaling its network and deepening AI capabilities to further reduce healthcare disparities and improve care quality. Trends such as increasing AI adoption in healthcare, regulatory support for digital health, and heightened focus on social determinants will shape their journey[1][4].
Their influence may evolve from a healthcare technology provider to a foundational platform powering a new era of super-abundant, human-centered healthcare. Continued innovation in AI-driven diagnostics, personalized treatment plans, and population health analytics will likely keep Akido Labs at the forefront of healthcare transformation, fulfilling their mission to make exceptional healthcare a basic human right[1][3].
Akido Labs has raised $60.0M across 1 funding round. Most recently, it raised $60.0M Series B in May 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2025 | $60M Series B | OAK HC/FT, Andrew Adams | KRM Interests LLC, Louis Beryl, Jeff Dean, Rohit Gupta, Future Communities Capital, Greco, SNR, Y Combinator | Announced |
Akido Labs was founded in 2015 by Jared Goodner (Founder) and Prashant Samant (Founder).
Akido Labs has raised $60.0M in total across 1 funding round.
Akido Labs's investors include Oak HC/FT, Andrew Adams, KRM Interests LLC, Louis Beryl, Jeff Dean, Rohit Gupta, Future Communities Capital, Greco, SNR, Y Combinator.
